comparemela.com

Latest Breaking News On - Etzer darout - Page 7 : comparemela.com

ImmunoGen, Inc. (NASDAQ:IMGN) Q4 2022 Earnings Call Transcript

Operator: Good morning, and welcome to ImmunoGen s Fourth Quarter and Full Year 2022 Financial and Operating Results Conference Call. Today s conference is being recorded.

United-kingdom
Mark-enyedy
Canaccord-genuity
Todd-talarico
John-newman
Anna-berkenblit
Anabel-chan
Etzer-darout
Oxford-biotherapeutics
Renee-lentini
Michael-vasconcelles
Michael-schmidt

Positive Report for Seagen (SGEN) from Raymond James

Seagen (SGEN – Research Report) received a Buy rating and a $175.00 price target from Raymond James analyst Dane Leone yesterday. The comp.

Etzer-darout
Dane-leone
Raymond-james
David-gryska
Seagen-inc
Research-report

Exelixis, Inc. (NASDAQ:EXEL) Q4 2022 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to the Exelixis Fourth Quarter and Full Year 2022 Financial Results Conference Call. My name is Vaishnavi, and I ll be your operator for today.

New-york
United-states
Delaware
America
Andy-hsieh
Asthika-goonewardene
Vicki-goodman
Susan-hubbard
Jason-gerberry
Mike-king
Mike-morrissey
Etzer-darout

Exelixis (EXEL) Q4 2022 Earnings Call Transcript

EXEL earnings call for the period ending December 31, 2022.

New-york
United-states
Delaware
Andy-hsieh
Asthika-goonewardene
Vicki-goodman
Susan-hubbard
Jason-gerberry
Mike-morrissey
Mike-king
Etzer-darout
Andy-hsieh-william-blair

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2022 Earnings Call Transcript

Operator: Good afternoon, and welcome to the Y-mAbs Therapeutics, Inc. Earnings Conference Call for the Third Quarter of 2022. .

Mexico
United-states
Israel
Belgium
Brazil
China
Colombia
Canada
America
Sue-smith
Canaccord-genuity
William-maughan

vimarsana © 2020. All Rights Reserved.